Cargando…
Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
INTRODUCTION: Natural killer cells can attack cancer cells without prior sensitization, but their clinical benefit is limited owing to their poor selectivity that is caused by the lack of specific receptors to target tumor cells. In this study, we aimed to endow NK cells with the ability to specific...
Autores principales: | Zheng, Youshi, Lai, Zisen, Wang, Bing, Wei, Zuwu, Zeng, Yongyi, Zhuang, Qiuyu, Liu, Xiaolong, Lin, Kecan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477160/ https://www.ncbi.nlm.nih.gov/pubmed/37665421 http://dx.doi.org/10.1007/s12672-023-00780-6 |
Ejemplares similares
-
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
por: Zhao, Menglong, et al.
Publicado: (2018) -
Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer
por: Park, Jun Young, et al.
Publicado: (2020) -
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021) -
Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022) -
Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
por: Yaguchi, Tomonori, et al.
Publicado: (2015)